XIMED
Business purpose.
Développement et commercialisation, de dispositifs médicaux.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Manufacture of irradiation, electromedical and electrotherapeutic equipment (26.60Z)
- Sector
- Manufacture of computer, electronic and optical products
- Headcount
- Headcount unknown
- Created
- 30 Jan 2024
- Share capital
- 13,871.00 EUR
- Financial year end
- 31/12
- Establishments
- 2
Directors
- Aboubakr BAKKALI 46 years old, 01/1980 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- IMACISIO via Aboubakr BAKKALI
Other companies at the same address
15 other company head offices are registered at this address.
Establishments
-
98413409800016 33400 TALENCE
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
66 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (2.8 years)
- 5.6 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la métallurgie du 7 février 2022 - Étendue par arrêté du 14 décembre 2022 JORF 22 décembre 2022
IDCC 3248 · in force, extended · 2 establishments · declared in August 2026
Legal notices
-
Amendment 21 Jun 2026
- Court :
- Greffe du Tribunal de Commerce de Bordeaux
- Amendment :
- transfert du siège social.
BODACC B n 20260116, annonce n 1440 · Proof of publication (PDF)
-
Filing of accounts 26 May 2026
- Court :
- Greffe du Tribunal de Commerce de bordeaux
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260098, annonce n 3146 · Proof of publication (PDF)
-
Amendment 13 Mar 2026
- Court :
- Greffe du Tribunal de Commerce de Bordeaux
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20260050, annonce n 989 · Proof of publication (PDF)
-
Incorporation 11 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de Bordeaux
BODACC A n 20240029, annonce n 546 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Filings and accounts
- Formality 25 Jun 2026
- Formality 26 Mar 2026
- Formality 11 Mar 2026
- Formality 8 Feb 2024
Change history
- Appointed: President de SAS 9 Oct 2026
- Share capital changed from 13,871 € to 10,000 € 2 Oct 2026
- Registered office: Rue François Mitterrand 33400 Talence 1 Oct 2026
- Registered office: 31 Rue Thomas Edison 33610 Canéjan 1 Oct 2026
- Share capital: 13,871 € 1 Oct 2026
Frequently asked questions about XIMED
- What is the SIREN number of XIMED?
- The SIREN number of XIMED is 984134098. Its intra-community VAT number is FR17984134098.
- Where is the head office of XIMED?
- Head office address: 31 RUE THOMAS EDISON, 33610 CANEJAN.
- When was XIMED founded?
- XIMED was founded on 30 Jan 2024.
- What does XIMED do?
- Its declared main activity is: Manufacture of irradiation, electromedical and electrotherapeutic equipment (NAF code 26.60Z).
- Who runs XIMED?
- The officer listed in the register is Aboubakr BAKKALI (President de SAS).
- Is XIMED subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.